Summary for Propofol


BreastfeedingPediatric
  • Trade Name: Diprivan (AstraZeneca)
  • Indications: Induction and maintenance of anesthesia
  • Class: Anesthetic; general
  • Half-life: initial: 40 minutes; terminal: 3 days
  • Clinically important, potentially hazardous interactions with:
    Zinc

Fospropofol disodium a prodrug of propofol was withdrawn in 2012.

Please login to view the rest of this drug profile.

Page last updated 03/01/2026

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top